Danaher Corporation
NYSEDHR short interest surges 21.5% in one week to 1.97% of free float, marking highest level since late June as stock struggles near $195.
A new long-form analysis for DHR this week — anomalies vs the company's own history, peer comparisons, news context, and the full data picture. Premium subscribers only.
Read on ORTEX →Sign up for premiumDanaher Corporation is now in damage-assessment mode — down 11% in a single session after Q2 results that exposed the bioprocessing recovery as slower and bumpier than the bulls had priced in. The analyst response on…
Snapshot as of 6 Aug 2026
Danaher Corporation arrives at its July 21 Q2 print with bears in full retreat and the options market tilting modestly more cautious — a shift from the relaxed tone noted just ten days ago. The short retreat has…
Danaher Corporation enters its July 21 Q2 earnings print with an unusual setup: short sellers have been cutting positions sharply while options markets show little sign of the hedging pressure that typically builds…
Danaher heads into the first week of June with options traders turning notably more constructive, even as the stock slips 2.1% on Tuesday to close at $176.11. The clearest shift this week is in the options market. The…
Danaher enters the back half of May with something it has lacked for most of the year: fresh analyst support. Citigroup reinstated coverage with a Buy and a $230 target on May 27. That follows RBC Capital doing the…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for DHR — free to start on ORTEX.
Sign up for free →Open DHR on ORTEX